(IN BRIEF) SGS has certified Yaoshi’s Yetsea 300 series ultra-widefield scanning laser ophthalmoscope under IEC 81001-5-1:2021 through the IECEE CB Scheme. SGS said the certification represents the first application of the health-software cybersecurity lifecycle standard within the global CB certification … Read the full press release
Posted in Business, Electronics & Machinery, Healthcare, Security & Safety, Switzerland, Technology
Tagged CB Certification, connected medical devices, digital trust, electrical safety, electromagnetic compatibility, EMC, Global market access, health software cybersecurity, healthcare technology, IEC 81001-5-1, IECEE CB Scheme, medical device certification, medical device cybersecurity, medical device testing, New Certification Supports Global Market Access for Yaoshi Yetsea 300 Series, ophthalmology, penetration testing, regulatory compliance, SBOM, SGS, SGS Assesses Yaoshi Cybersecurity Controls for Ultra-Widefield Ophthalmic Device, SGS DIGITAL TRUST, SLO, software bill of materials, source code audit, threat modelling, ultra-widefield scanning laser ophthalmoscope, vulnerability scanning, Yaoshi, Yaoshi Receives Reported First IECEE CB Certification Under IEC 81001-5-1, Yetsea 300
(IN BRIEF) The US Food and Drug Administration has accepted and granted Priority Review to Roche’s supplemental Biologics License Application for Enspryng, or satralizumab, in thyroid eye disease. The application is supported by data from the Phase 3 SatraGO-1 and … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged at-home treatment, autoimmune disease, Chugai, clinical activity score, clinical development, diplopia, Enspryng, Enspryng Could Become At-Home Subcutaneous Treatment Option for Thyroid Eye Disease, Enspryng Phase 3 Programme Shows Improvements in Key Thyroid Eye Disease Measures, FDA, FDA Priority Review Supports Roche’s Planned Expansion of Enspryng Into Thyroid Eye Disease, Graves’ ophthalmopathy, IL-6 receptor, Levi Garraway, neuromyelitis optica spectrum disorder, NMOSD, ophthalmology, Phase 3 clinical trial, Priority Review, proptosis, rare disease, regulatory submission, Roche, SatraGO-1, SatraGO-2, satralizumab, sBLA, subcutaneous treatment, supplemental Biologics License Application, TED, thyroid eye disease, US Food and Drug Administration
(IN BRIEF) Sanofi has appointed Paulo Fontoura as Executive Vice President and Global Head of Research & Development Pharma, effective September 1, 2026. Based in Paris and reporting to CEO Belén Garijo, Fontoura will join Sanofi’s Executive Committee and lead … Read the full press release
Posted in Artificial Intelligence (AI), Business, France, Healthcare, Management, Pharma & Biotech, Science
Tagged American Academy of Neurology, artificial intelligence, Belén Garijo, biopharma, breakthrough therapies, clinical development, clinical scientists, drug discovery, EMA approvals, FDA approvals, generative AI, Global Head of R&D Pharma, Houman Ashrafian, immunology, infectious diseases, neuroimmunology, Neurology, neuroscience, new molecular entities, New University of Lisbon, ophthalmology, Paulo Fontoura, Paulo Fontoura to Lead Sanofi’s Global R&D Organisation from September 2026, pharmaceutical innovation, pharmaceutical research and development, physician-scientist, pipeline development, R&D transformation, rare diseases, regulatory affairs, Roche, Sanofi, Sanofi Appoints Paulo Fontoura as Global Head of Pharmaceutical Research and Development, Sanofi Executive Committee, Sanofi Selects Paulo Fontoura to Advance Global Pipeline and AI-Enabled R&D Strategy, Sanofi Strengthens Research and Development Leadership with Paulo Fontoura Appointment, Stanford University, translational medicine, Xaira Therapeutics
(IN BRIEF) ZEISS Medical Technology has entered into a strategic collaboration with Envision Health Technologies to advance virtual reality-based visual function testing for glaucoma care. The partnership combines ZEISS’ long-standing expertise in perimetry and visual field testing with Envision’s software-driven … Read the full press release
Posted in Artificial Intelligence (AI), European Union, Germany, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged Anuj Kalra, Carl Zeiss Meditec AG, chronic disease management, clinical credibility, clinical rigour, clinician-driven innovation, data-driven solutions, digital eye health, Dr Lama A Al-Aswad, Envision Health Technologies, eye health technology, gamified virtual reality, Germany, glaucoma care, glaucoma diagnostics, glaucoma screening, Jena, medical technology, modern glaucoma care, ophthalmology, patient-accessible testing, patient-centred care, perimetry, portable testing, software-driven diagnostics, virtual reality testing, vision-threatening diseases, visual field testing, visual function testing, VR perimetry, ZEISS Advances Digital Glaucoma Testing Strategy Through Collaboration with Envision Health Technologies, ZEISS and Envision Health Technologies Combine Perimetry Expertise and VR Innovation for Eye Care, ZEISS Medical Technology, ZEISS Partnership with Envision Health Technologies Targets Software-Driven Glaucoma Diagnostics
(IN BRIEF) ZEISS Medical Technology has announced successful early clinical implantations of the ZEISS AT LUCIA toric 721P intraocular lens, a new CE-marked IOL designed to treat cataracts while correcting astigmatism. The lens combines an aspheric bitoric optic with ZEISS’ … Read the full press release
Posted in Czech Republic, Electronics & Machinery, Germany, Government, Healthcare, Italy, Pharma & Biotech, Science, Technology
Tagged anterior segment surgery, aspheric bitoric optic, astigmatism correction, Ayrshire Eye Clinic, Carl Zeiss Meditec AG, cataract surgery, CE marked, Czech Republic, DOC, Dr Amin-Robert Kassem, Dr Andrea Janeková, Dr Helena Noguera, early-access clinical trial, European clinical trial, eye care, Eye Center Prague, Frank Seitzinger, fully preloaded IOL, Galdácano-Usansolo University Hospital, Germany, hydrophobic c-Loop platform, International Congress of German Ophthalmic Surgery, intraocular lens, IOL, Jena, Miranza COI Bilbao, non-constant aberration design, Nuremberg, ophthalmic surgery, ophthalmology, Prof Sathish Srinivasan, refractive outcomes, rotational stability, Scotland, Spain, Surgical Innovation, Sweden, toric IOL, United Kingdom, Värnamo Eye Center, visual outcomes, ZEISS, ZEISS Advances Cataract and Astigmatism Treatment With Early Clinical Success for AT LUCIA Toric 721P IOL, ZEISS Announces Successful Early Implantations of AT LUCIA Toric 721P Intraocular Lens Across Europe, ZEISS AT LUCIA toric 721P, ZEISS AT LUCIA Toric 721P Intraocular Lens Shows Positive Early Surgeon Feedback in European Trial, ZEISS Expands Ophthalmic Surgery Portfolio With New Toric IOL Designed for Precision and Long-Term Stability, ZEISS Medical Technology, ZO optic
(IN BRIEF) Carl Zeiss Meditec has received regulatory approval from Mexico’s COFEPRIS authority for the ZEISS ARTEVO 850 ophthalmic surgical microscope and the ZEISS MICOR 700 lens removal device. The newly approved technologies expand ZEISS’s ophthalmic surgery portfolio in Mexico … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Science, Technology
Tagged ARTEVO 850, CALLISTO eye, Carl Zeiss Meditec, cataract surgery, cataract treatment, COFEPRIS, digital visualization, Eye Surgery, Frank Seitzinger, Germany, healthcare technology, Jena, medical devices, medical technology, Mexican Congress of Ophthalmology, Mexico, MICOR 700, Monterrey, NULEX, ophthalmic microscope, ophthalmic surgery, ophthalmic workflows, ophthalmology, PT Cheong, Surgical Innovation, surgical microscope, ultrasound-free lens extraction, vision care, ZEISS, ZEISS Expands Cataract Surgery Technology Portfolio in Mexico With COFEPRIS Approvals, ZEISS expands ophthalmic surgery portfolio in Mexico following COFEPRIS approval for ARTEVO 850 and MICOR 700, ZEISS Introduces Advanced Ophthalmic Visualization and Lens Extraction Systems to Mexican Market, ZEISS Strengthens Digital Cataract Surgery Workflow Offering Through New Mexican Approvals
(IN BRIEF) EssilorLuxottica showcased an integrated scientific ecosystem spanning the full eye care continuum at ARVO 2026. The company combined capabilities from Heidelberg Engineering, RetinAI, and Espansione to demonstrate how advanced imaging, AI-powered analytics, diagnostics, and therapeutic technologies can support … Read the full press release
Posted in Apparel, Fashion & Beauty, Artificial Intelligence (AI), Business, France, Management, Marketing, News, Technology
Tagged AI diagnostics, artificial intelligence, ARVO 2026, clinical research, diabetic retinopathy, digital ophthalmology, espansione, Essilor Stellest, EssilorLuxottica, EssilorLuxottica Expands Vision Science and Medical Technology Integration Through ARVO Showcase, EssilorLuxottica Presents Integrated AI-Driven Eye Care Ecosystem at ARVO 2026, Ettore Mosca, eye care innovation, eye-light platform, healthcare technology, Heidelberg Engineering, Leonardo learning ecosystem, Medical Technologies, multimodal imaging, myopia management, Norbert Gorny, OCT imaging, Olga Prenat, ophthalmic research, ophthalmology, photobiomodulation, RetinAI, retinal imaging, retinal therapy, vision care, vision science
(IN BRIEF) EssilorLuxottica has announced plans to acquire Signifeye, a leading Belgian ophthalmology platform operating 15 clinics across the Flanders region, further expanding its presence in specialized eye care. The deal follows the recent acquisition of Optegra and supports the … Read the full press release
Posted in Apparel, Fashion & Beauty, Belgium, Business, France, Healthcare, Investment, Management, News, Technology
Tagged Belgium, clinical excellence, EssilorLuxottica, EssilorLuxottica Strengthens Integrated Medical Vision Strategy Through Signifeye Acquisition, European clinics, eye care, Flanders, Francesco Milleri, healthcare acquisitions, Kathleen Moons, med-tech, ophthalmology, Optegra, patient care, Paul du Saillant, Signifeye, vision care
(IN BRIEF) Sandoz has launched Afqlir®, its biosimilar to aflibercept, across Europe following European Commission approval in 2024. Equivalent in efficacy, safety, and pharmacokinetics to Eylea®, Afqlir® provides a lower-cost treatment option for serious retinal diseases such as nAMD, RVO, … Read the full press release
Posted in Business, Healthcare, Marketing, News, Pharma & Biotech, Switzerland
Tagged aflibercept, Afqlir, anti-VEGF market, biologic medicines, biosimilar portfolio, biosimilars, Christophe Delenta, DME, European Commission approval, European Rollout of Afqlir Marks Major Step in Sandoz Expansion Across Anti-VEGF Ophthalmology Market, Eylea, intravitreal injection, mCNV, nAMD, ophthalmology, retinal diseases, RVO, Sandoz, Sustainable Healthcare, vision loss treatment
(IN BRIEF) EssilorLuxottica has joined the Collaborative Community of Ophthalmic Innovation (CCOI), reinforcing its commitment to advancing patient-centered eye-health solutions through global scientific collaboration. By participating in this international network of clinicians, researchers, regulators, industry, and patient groups, the company … Read the full press release
Posted in Apparel, Fashion & Beauty, France, Healthcare, Management, News, Technology
Tagged age-related macular degeneration, artificial intelligence, CCOI, clinical research, Collaborative Community of Ophthalmic Innovation, diagnostics, digital health, EssilorLuxottica, EssilorLuxottica Expands Its Influence in Vision Research by Becoming a Vision Architect Member of the CCOI, glaucoma, global eye health, Heidelberg Engineering, Malvina Eydelman, medical imaging, myopia, Norbert Gorny, oculomics, ophthalmology, optical engineering, patient-centered innovation, scientific collaboration, Sustainable Healthcare
(IN BRIEF) Roche has announced new data at the Euretina Congress in Paris from its AVONELLE-X and SALWEEN studies of Vabysmo (faricimab), confirming the therapy’s strong long-term outcomes for patients with retinal diseases. The AVONELLE-X study, the largest long-term extension … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AVONELLE-X, bispecific antibody, diabetic macular edema, DME, durability, Euretina Congress, extended dosing, faricimab, Levi Garraway, long-term efficacy, LUCERNE, nAMD, neovascular age-related macular degeneration, ophthalmology, PCV, polypoidal choroidal vasculopathy, retinal vein occlusion, Roche, RVO, SALWEEN, TENAYA, Vabysmo, vision loss
(IN BRIEF) ZEISS Medical Technology has received CE mark approval for CIRRUS PathFinder, an integrated AI decision support tool for optical coherence tomography (OCT). The software, available as part of a new CIRRUS update, leverages deep learning algorithms to automatically … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged AI in healthcare, Anuj Kalra, CE Mark, CIRRUS PathFinder, clinical decision support, Cybersecurity, deep learning, diagnostic imaging, digital health, Euan S. Thomson, eye care, Magnus Reibenspiess, medical technology innovation, OCT, OCTA, ophthalmology, ZEISS Medical Technology
(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release
Posted in Austria, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science
Tagged anti-allergic medication Pollival, anti-COVID therapeutics, antihistamine drug, antiviral properties, azelastine, azelastine hydrochloride, CEBINA GmbH, Central European Biotech Incubator and Accelerator, clinical trial, COVID-19, COVID-19 medication, Covid-19 pandemic, COVID-19 treatment, nasal spray, ophthalmology, Pollival, Prof Dr Robert Konrat, Prof Dr. Ferenc Jakab, re-purpose drugs, SARS-CoV-2, Sophie Zettl, University of Pécs, University of Vienna, URSAPHARM Arzneimittel GmbH, viral spread
Alcon SMART Suite, powered by Philips’ HealthSuite digital platform, aims to drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients AMSTERDAM, 24-Oct-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?